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Gabriel L. Gellert 
 
COMPARATIVELY BENCHMARKING GOVERNMENT PANDEMIC RESPONSE EFFECTIVENESS AND ETHICS 
Since SARS-CoV-2 first emerged in December 2019 in Wuhan, China, COVID-19 has become a global 
pandemic that continues to challenge and undermine the economies and health care systems of many 
nations. While clinical experience and research with other coronaviruses are extensive, the SARS-CoV-2 
attack on humanity has been characterized by vulnerabilities that have origins within, or have been 
severely exacerbated by, political polarization and underlying ethical issues including racial/ethnic, 
socioeconomic and public health inequities (Gellert, 2020; Burki, 2020; Thomson & Ip, 2020; Haug et al., 
2020; Harris & Holm, 1995). Given global spread of the virus and its continuing mutation into more 
transmissible variants, eradication of SARS-CoV-2 is imperative but could be hobbled by these issues.  
The ethical and political roots of COVID-19 disease control challenges warrant evaluation, and 
can be illustrated by comparing the first year (calendar 2000) pandemic control performance of the 
governments and public health systems of China, Canada and the U.S. In comparing and contrasting the 
course of governmental public health policies and practices across these nations, other critical historical, 
socioeconomic, and cultural considerations are reviewed with an eye towards understanding how each 
has impacted community viral transmission, resultant morbidity and mortality, and both curative and 
preventive health care delivery.  
In particular, we will focus on the impact of racial, socioeconomic and health care inequities, 
general level of societal political polarization and fragmentation, mounting government distrust among 
the public, denigration, denial and distrust of science, politicization of the pandemic and of disease 
control and mitigation strategies, and level of governmental leadership, active engagement and 
direction of a national pandemic control strategy and associated tactics.  
 
CHINA’S FIRST YEAR PANDEMIC RESPONSE: EMULATED ARCHETYPE OF DISEASE CONTROL ROOTED IN 
AUTHORITARIAN POWER, GOVERNMENT, AND HEALTH ETHICS 
China’s government rapidly implemented an effective and authoritarian program of disease control 
measures involving severe restrictions on movement and public social distancing/isolation that would 
have been difficult to replicate in democratic nations. Wuhan and Hubei province went on a strict 
lockdown lasting 76 days. Public transport was suspended and population movements severely 
restricted; only one member per household could leave home to collect necessary supplies (Burki, 2020). 
Across China, 14,000 health checkpoints were established at public transport hubs and school re-
openings suspended, among other measures (Burki, 2020; Thomson & Ip, 2020).  
China’s first year pandemic response was effective in interrupting community transmission of the 
virus, achieving among the largest, most rapid reductions in disease incidence in the world. By October 
2020, China had 90,604 cases of COVID-19 and 4739 deaths, while the U.S. had 7,382,194 cases and 
209,382 deaths (Burki, 2020). However, the public health ethics of China’s effective disease control 
efforts were based in and empowered by prevailing fear of its authoritarian form of coercive governance, 
policing and political culture (although historically Chinese culture/ethos emphasize collective good over 
the individualism characteristic of American culture).  
While many nations may envy China’s pandemic performance success, few among the liberal 
democracies would admit to emulating its public health ethics and suppression of civil liberties in 
curtailing viral spread. Further, China’s authoritarian information control and politics may have impeded 
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an early provincial response to COVID-19, which could have mitigated spread of the virus globally 
(Thomson & Ip, 2020). 
 Nonetheless, democratic states also deployed extraordinary governmental powers to reduce 
SARS-CoV-2 transmission within their borders, including Australia and South Korea, which were also 
among the most successful of nations in preventing extensive national outbreaks of COVID-19. Thomson 
and Ip argue that many nations (including liberal democracies) pursued disease control objectives by 
engaging authoritarian values. This included policies overriding and eroding human rights and civil 
liberties, including restrictions on freedom of movement and freedom from government surveillance, 
governmental and administrative overreach, adoption of excessive and disproportionate emergency 
measures, failure to engage deliberative and transparent decision-making, and suspension of effective 
democratic control (Thomson & Ip, 2020).  
Replication of China’s approach, involving authoritarianization of measures exceeding that 
demanded for effective disease control, occurred in many nations, including Bosnia and Herzegovina, 
Cambodia, France, Germany, Hong Kong, Hungary, India, Kosovo, the Philippines, Scotland, Serbia, 
Slovenia, South Korea, the United Kingdom and Wales (Thompson & Ip, 2020). Thompson and Ip suggest 
that a “transnational constitutional pandemic” may be evident, in which a COVID-19 control at any cost 
ethos, driven in part by public health authorities, became an agent or catalyst for authoritarianization in 
democratic states as well as fundamental breaches in public health and health care ethics (Thomson & 
Ip, 2020). 
However, in contrast to the above, Haug et al. found that disease control measures that the 
public may have viewed as excessive or coercive were in fact highly effective in containing the community 
spread of SARS-CoV-2 (Haug et al., 2020). Furthermore, it has been argued that pandemics require the 
application of collective ethics, where there exists a moral obligation not to infect other individuals 
(Harris & Holm, 1995). Collective ethics recognizes that the bioethical principle of individual autonomy 
and choice must be informed by the human rights of beneficence and non-maleficence, codified in the 
Helsinki Declaration, which in pandemic control translates into an understanding that individual civil 
liberties do not include a liberty or right to infect others.  
While this tension has been evident in many nations around the issue of vaccine mandates and/or 
wearing of masks to reduce viral spread, it is most notable in the United States where amidst abundant 
vaccine supply, some 30% of the eligible population resists vaccination. As will be discussed, this 
polarization in the American public’s views on reasonable, appropriate and ethical disease control 
measures has been exacerbated by key trends, including distrust of science and of government that has 
been building for decades but has been greatly exacerbated during the last presidential administration. 
The U.S. government’s embrace of authoritarianism during the presidency of Donald Trump 
predated the pandemic. Mr. Trump upended most historical norms of American presidential governance, 
continually conveyed disinformation and falsehoods to the public about many issues, including the 
pandemic, and sought to expand his personal power through autocratic tactics that continued through 
his re-election bid and beyond. However, Mr. Trump’s pursuit of authoritarian power in the first year of 
the pandemic, unlike that in other nations, sought to delimit and undermine, rather than ensure, 
effective pandemic disease control in the U.S.  
Unlike most other national leaders, Mr. Trump leveraged the power and platform of his 
leadership office to question the disease control value of essential COVID-19 prevention strategies such 
masking, social distancing, and suspension of non-essential public activities to inhibit viral transmission. 
While Mr. Trump aspired for authoritarian power exercised by autocratic regimes such as China, his 
approach to managing the pandemic was to consistently evade and abrogate federal and presidential 
responsibility to coordinate pandemic response across the states and among his own governmental 
agencies.  
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Mr. Trump failed to lead an essential national effort to coordinate and deliver a coherent, 
effective effort to interrupt community transmission of the virus, ensure supply of essential materials to 
prevent and treat infection, and plan for eventual vaccine distribution. Unlike nations where authoritarian 
power and tactics were deployed (and rationalized) to ostensibly improve pandemic performance, Mr. 
Trump used presidential power to disrupt and undermine institutions/individuals seeking to improve 
disease control. This included his own White House Coronavirus Taskforce, his advisors from the U.S. 
Centers for Disease Control and Prevention (CDC) and National Institutes of Health, and state governors 
endeavoring to compensate for the failure of the federal government to effectively engage its critical 
leadership role in pandemic response.  
U.S. failures in the first year of the national pandemic control effort were not only based on Mr. 
Trump’s aversion to leading the response, but also rooted in other characteristics of U.S. national ethos, 
culture and society which can be best elucidated through comparison to its neighbor and largest trade 
partner, Canada. 
 
ETHICAL BASIS OF CANADA’S SUPERIOR FIRST YEAR PANDEMIC CONTROL PERFORMANCE VERSUS THE 
U.S. 
Prior to the pandemic the U.S., with its technologically advanced hospital and public health resources 
and infrastructure, including the CDC, would be expected to perform better than most of the world’s 
nations. However, by virtually any metric, the first year pandemic control performance of the U.S. (before 
vaccines were available) was dismal. Canada, for example, has had less cases, hospitalizations and deaths 
per capita than the U.S. Canada’s total deaths as a percentage of population (0.06%) is less than half that 
of the U.S. (0.16%) (World Health Organization, 2021). There are multiple contributors to these divergent 
national disease control performances and outcomes. 
 
Better Aligned Single Payer Provincial Health Care Systems Enabling More Coherent National 
Pandemic Response   
Unlike the U.S., Canadian pandemic control efforts may have benefited from having a single payer health 
care system across its 13 provinces and territories. Even though each Canadian province determined its 
pandemic containment and mitigation strategy, Canada’s public health and care delivery systems are 
less fractured and more integrated than the mixed governmental-private industry-based health system 
across 56 U.S. states, districts and territories, each of which effectively comprises its own commercial 
health care market. A single payer system in Canada (and other nations) enabled rapid, uniform 
provincial implementation of disease control directives and actions, and better management of critical 
supply chains of personal protective equipment, ventilators and other essential materials in early 
governmental pandemic response (Detsky & Bogoch, 2020).  
In the U.S., complexities of the interplay between local, state and federal authority and disease 
control policies/processes have been described in past outbreak response performance of a novel 
pathogen (Gellert, 1994), whereas in Canada there was strong cooperation between federal and 
provincial officials and politicians, with little acrimony or conflicting messaging between levels of 
government (Detsky & Bogoch, 2020). Along with the intense current polarization of U.S. political parties 
at the state and federal levels, these factors may have complicated rapid, pan-national adoption of 
uniform COVID-19 infection prevention strategies in the U.S. compared with either Canada or China. 
Other nations with single payer health care systems also performed far better than the U.S. in 
pandemic disease control, including Australia, New Zealand, South Korea and Taiwan (World Health 
Organization, 2021). Establishment of a single payer health care system demonstrates unified national 
political will, faith in government competence, and social values that can help enable greater social 
cohesion and operational coherence in pandemic response. The U.S. is the sole economically advanced 
nation without a single payer health care system, and continues to have large segments of its population 
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uninsured or under-insured, positioning it among the affluent nations of the world as an outlier in public 
health ethics, and predisposing it to early difficulty rapidly mobilizing a uniform, truly national pandemic 
response.  
 
More Pervasive U.S. Socioeconomic, Racial and Health Care/Public Health Inequity 
The health care and public health marginalization of lower income groups and underserved minorities in 
the U.S., who often lack health insurance, has fostered poor health outcomes and general distrust of 
government. This may have contributed to less willingness to engage COVID-19 preventive measures 
when government advised.  
Canada, while still having significant inequities affecting the health of Native/Indigenous 
Canadians and its homeless population, is considerably less racially, politically and socioeconomically 
polarized than the U.S. For three years before the pandemic, the Trump administration further 
exacerbated longstanding political and racial/ethnic polarization and fears in U.S. society, adding to 
longstanding American social, economic, health care and public health inequities that may have 
contributed to disproportionate rates of infection, hospitalization, and deaths among American minority 
racial and ethnic groups.  
American minorities also disproportionately populated lower paying service industry jobs during 
the pandemic that bore greater risk of infection and have no work from home option. The impact of these 
realities is evidenced by lower COVID-19 vaccine uptake among Black and Latinx Americans, their 
disproportionate COVID-19 mortality rates, and declines in life expectancy (Barbieri, 2021). Since 2020, 
Latinx American life expectancy has declined 3.9 years, and for Black Americans life expectancy declined 
3.2 years, versus 1.4 years among whites (Barbieri, 2021).  
 
U.S. Political Polarization, Anti-Government Distrust and Politicization of the Pandemic 
Superior societal levels of public trust of government may have given Canada an advantage over the U.S. 
during the first-year pandemic response. Canada has less underlying political polarization than the U.S., 
and as a result, the pandemic was not politicized in Canada to the extent it was in the U.S. (Detsky & 
Bogoch, 2020). While some Canadians harbor anti-government sentiments, under the Trump 
administration, a substantial part of the U.S. population reached a peak in government distrust which 
began in the Vietnam conflict and the Watergate crisis, and was institutionalized when President Ronald 
Reagan stated, “government is not the solution to our problem, government is the problem” (Greider, 
2018).  
Anti-government sentiment in the U.S. over the last 40 years has been elevated essentially as a 
political belief system, and as a core value, identity and influence largely within members of the 
Republican Party (Greider, 2018). This anti-government sentiment contributed to a sustained multi-
decade decrease in support and investment in the U.S. public health system, the capabilities of which 
have eroded since 1980, hindering public health mobilization in the early U.S. pandemic response.  
Mr. Reagan’s condemnation of the use of governmental power as a problem, rather than a 
solution, and of government institutions as inept, which Republican leaders embraced - Newt Gingrich in 
the 1990s and Mr. Trump more recently - fostered chronic under-funding of the American public health 
system. It enabled and powered a self-fulfilling prophecy of government incapacity and ineptitude in first 
year U.S. pandemic response, and contributed to a slow U.S. disease control mobilization. These factors 
contributed to the disproportionately high American death toll during the first year of the pandemic 
relative to other nations. A pandemic of this complexity cannot be controlled within a political 
environment where the national leadership and policy-making systems have grown increasingly 
dysfunctional due to extraordinary political polarization, pervasive anti-government sentiment, and 
unwillingness to invest funds to meet public needs within of one of the two major political parties.  
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Mr. Trump exploited and expanded public distrust of government to mitigate any threat he 
perceived to his incompetent, disinterested governance (or to his re-election), including his inability to 
lead a science-based, coherent and effective national pandemic response. As a result, his public 
statements constantly attacked evidence-based science and medical orthodoxy and questioned the 
validity of epidemiological projections of COVID-19 incidence and severity. He undermined the policies 
and actions of his own public health leadership team, including efforts to promote preventive practices 
whereby the public could reduce community transmission of SARS-CoV-2.  
Further, it appears Mr. Trump had information before the pandemic emerged in the U.S. about 
how highly contagious and deadly SARS-CoV-2 could be (Woodward, 2020). Given Mr. Trump’s advance 
knowledge of the imminent harm of the pandemic in his own nation, his continual denial of the 
pandemic’s lethal potential, and his undermining of federal and state government public health agencies 
and leaders, evidences an historically unprecedented breach of public health ethics and intentional public 
health malfeasance (Gellert, 2021).  
Mr. Trump also articulated unscientific views and misinformation on infection risk, disease 
outcomes and specific therapies without evidence, such as the potentially lethal inhalation of highly toxic 
bleach as a means to clear the lungs of the virus, and he personally modeled non-compliant behaviors 
around social congregation and distancing in the White House (resulting in an outbreak of SARS-CoV-2 
transmission among White House guests and staff). These behaviors undermined the American public’s 
trust and confidence in their government, in science and public health at precisely the moment it was 
most needed to mitigate expansion of the U.S. epidemic.  
This contrasts dramatically with the behavior, actions and policies of Prime Minister Justin 
Trudeau and the provincial premiers of Canada, who lent strong support to evidence- and science-based 
disease control policies and practices, and empowered government agencies with resources and 
direction. Instead of embracing and advocating on behalf of government-based medical and public 
health science in his pandemic response like Canadian leaders, Mr. Trump continually questioned and 
politicized the integrity and accuracy of the emerging scientific consensus within his own governmental 
scientific agencies on how to prevent SARS-CoV-2 infection, and publicly criticized and bickered about 
the pandemic response of state governors (particularly if from the Democratic and not his own 
Republican political party). In contrast, while by no means entirely conflict free, in Canada the federal and 
provincial governments cooperated with one another despite differences in political party affiliation 
(Detsky & Bogoch, 2020). Mr. Trump’s consistent efforts to deconstruct and nullify a science-based, 
effective pandemic response represent further breaches of public health ethics and one of the greatest 
betrayals of the American public’s trust in U.S. history. 
 
More Engaged, Effective National and Regional Pandemic Control Leadership  
As noted, early in the pandemic Canada's national and provincial governments understood and 
embraced their role in leading a national pandemic response. This was seen in Canada, and in most other 
nations, as a public health - and an ethical - imperative to lead responsibly and protect the public from 
harm. In contrast, Mr. Trump and aligned Republican congressional representatives and governors 
effectively abandoned the essential and critical governmental role of leading a U.S. national response 
strategy, and left the individual U.S. states and counties to fend for themselves for critical pandemic 
response resources, including essential personal protective equipment, ventilators and COVID-19 testing 
supplies. As the virus spread, Mr. Trump continued for months to deny that a national epidemic was 
emerging as cases and deaths mounted and, without evidence, provided false reassurances to the public 
that the pandemic would end spontaneously on its own without public health intervention and national 
leadership.  
In Canada, neither Mr. Trudeau nor any provincial leader publicly doubted the seriousness of the 
threat and challenges that the pandemic posed, or the need to aggressively mobilize to contain it (Detsky 
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& Bogoch, 2020). Canadian political and public health leadership was effective in engaging public 
adherence to preventive measures (Detsky & Bogoch, 2020). The lack of U.S. national pandemic control 
leadership, and the crucial time lost as the virus was transmitted geometrically across the nation, crippled 
the critical first year U.S. pandemic response, and enabled the virus to spread widely within the American 
population. It contributed directly to the fact that absolute and per capita preventable COVID-19 
mortality in the U.S. was among the highest in the world. In contrast to Mr. Trump, Prime Minister 
Trudeau and provincial leaders seized the mandatory governmental leadership role in deploying all of the 
scientific and public health resources and capabilities of Canadian government to combat the pandemic. 
Understanding the powerful symbolism and educational value of his role as a national leader, unlike Mr. 
Trump, Prime Minister Trudeau modeled personal infection preventive measures.  
 
Science Denial and Denigration 
From early in the pandemic, while Prime Minister Trudeau and Canada’s provincial leaders embraced, 
invested in and supported Canada's public health science leadership and professionals, Mr. Trump 
downplayed evidence indicating the actual/potential severity of the pandemic, consistently denied 
evidence-based scientific realities around viral transmission, minimized the individual risk and potential 
severity of infection, and ignored his own pandemic response leadership team. This was a profound and 
unprecedented breach of public health ethics by Mr. Trump, particularly given his admission of advance 
knowledge of the potential destruction of the pandemic (Woodward, 2020).  
Compared to the U.S., there is considerably less public distrust of science and medical science 
authorities in Canada (Detsky & Bogoch, 2020). Mr. Trudeau and Canadian provincial leaders strongly 
supported scientific, evidence-based pandemic control policies and practices, such as masking and social 
distancing, which Mr. Trump dismissed, ignored or denigrated. Mr. Trump’s personal efforts to deny, 
delegitimize and dismiss medical science and COVID-19 preventive measures influenced large segments 
of U.S. society. Across socioeconomic strata, individuals in Mr. Trump’s political base absorbed and 
echoed his denial/delegitimization of science and his stigmatization of COVID-19 personal preventive 
measures. In a remarkable display of disinformation, measures to prevent disease spread were 
characterized as governmental abuses of power and coercion to deprive U.S. citizens of their civil and 
legal rights. This great public disservice continues to enable higher community transmission of the virus 
in Trump aligned jurisdictions despite vaccine availability.  
Even after departing the presidency, the cumulative toxic impact of Mr. Trump’s anti-science 
views and anti-government rhetoric is evidenced in lower vaccination rates among his followers in 
Republican-leaning states, where vaccination efforts are viewed as government forcibly coercing 
universal vaccination, despite no such policy articulation by any U.S. public health jurisdiction. A 
nationwide survey showed stark differences between Republicans and Democrats in vaccine uptake:  
86% of Democrats have received one dose of vaccine versus only 45% of Republicans (Balz & Guskin, 
2021). While only 6% of Democrats stated they are unlikely to get vaccinated, 47% of Republicans did 
(and 38% state they will definitely not ever) (Balz and Guskin, 2021). At a recent Republican political 
conference, Mr. Trump took credit for decades of vaccine research and development, claiming to have 
saved 100 million lives, but made no call for people to get vaccinated (Collinson, 2021). This breach of 
public health ethics by Mr. Trump and Republican leaders could have a devastating lethal impact if more 
infectious variants such as Delta become dominant in the U.S. and as low vaccination rates enable deadly 
surges in Republican states in the coming winter. 
 
MOVING FORWARD: RESISTING PANDEMIC NATIONALISM AND ISOLATIONISM 
A massive global effort is needed to supply vaccines, personal protective equipment, treatments and 
technology to low- and middle-income nations where high incidence of viral infection can serve as a 
breeding ground for SARS-CoV-2 variants (Trevisani, 2021). While this moral imperative is driven by 
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public health ethics and humanitarian need, it is clearly also a matter of every nation’s public health 
security and self-interest given global health interdependence (Gellert, 2020). Pandemics by their nature 
demand shared, collective public health security.  
At present, 50.6% of the global population has received one dose of COVID-19 vaccine, but only 
3.5% of the population of low-income nations and only 8.5% of Africa’s population have been vaccinated 
(Our World in Data, 2021; Holder, 2021). Over 5-6 billion people remain at risk and are potential viral hosts 
for the evolution of new variants. Currently approximately 24 million individuals are vaccinated daily (Our 
World in Data, 2021), thus we are months and likely years away from achieving global herd immunity 
under ideal conditions, without considering impediments to reaching the most underserved and rural 
communities. 
A multinational effort is needed to interrupt global viral transmission on a sustained basis 
through vaccination. The alternative is that all nations, including affluent nations that are progressing 
toward vaccine-induced herd immunity like the U.S., will play SARS-CoV-2 variant Russian roulette, 
where each new variant of the virus can potentially erode or evade current vaccines’ efficacy, much as 
the Delta variant has done with respect to (thankfully mostly mild) breakthrough infections of fully 
vaccinated individuals. There is no a priori way to assess the risk of a future variant reducing the 
continuing efficacy thus far of the vaccines to prevent severe disease requiring hospitalization or causing 
death.  
Failure to engage an aggressive program to reduce SARS-CoV-2 transmission around the globe 
will portend a catastrophic failure of public health ethics as well as public health efficacy. Nations 
achieving a respite from the pandemic due to effective national immunization must avoid public health 
nationalism and isolationism, and must eschew complacency about a virus that is continually evolving 
and successfully exploiting human behavioral, social, economic, political and inequity vulnerabilities to 
propagate itself at the expense of the human species. 
 
LEARNING FROM AN HISTORIC FAILURE IN PRESIDENTIAL ETHICS 
Comparative analysis of the relative success of first year pandemic control efforts in China, Canada and 
the U.S. illustrates the complexity of factors influencing national public health outcomes even within 
liberal democracies, which unlike China, face the challenge of balancing personal civil liberties and rights 
against restrictive disease control measures imposed. In the U.S., a convergence of complex political, 
socioeconomic, inequity and cultural influences created a perfect storm of rapid viral spread, with the 
U.S. first year pandemic performance and total deaths among the worse on the planet. However, the 
second year of U.S. national pandemic response illustrates the remarkable recovery power of effective 
national political leadership to drive success in pandemic control, with the U.S. vaccinating its large 
population at a rate among the highest in the world.  
In coming years, estimates will be generated of how many of the 529,000 first year pandemic 
deaths from COVID-19 in the U.S. could have been prevented, had Mr. Trump not abandoned his ethical 
responsibilities to deploy, rather than undermine, American public health and medical science in the 
national disease control effort. Past presidents were also criticized for slow or indifferent reactions to 
prior pandemics. By the time Ronald Reagan addressed the HIV/AIDS pandemic in 1987, 283,000 
Americans had died from the infection (Gibson, 2015). Over 700,000 have now died from HIV/AIDS in our 
nation, but as the U.S. climbs toward 800,000 deaths from COVID-19, the magnitude of Mr. Trump’s 
public health negligence and malfeasance becomes clear in considering that while the American 
HIV/AIDS death toll occurred over 40 years, it has taken COVID-19 less than three years to exceed the 
number of AIDS deaths.  
The mismanagement of the first year COVID-19 pandemic response in the U.S. was a massive 
governmental and public policy failure as measured by the American death toll, far exceeding what many 
regard as the greatest failure in presidential leadership of the last century:  the nation’s 21-year insertion 
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into the Vietnamese civil war from 1954 to 1975. Even if only 20% of the 529,000 American deaths from 
COVID-19 in the first year of the pandemic could have been prevented by better presidential and 
Congressional engagement and leadership, this would still be almost twice the total of American deaths 
resulting from the entire Vietnam conflict. This unprecedented failure in first year national pandemic 
leadership was rooted in an abdication of health ethics that are foundational to modern public health 
practice. 
Historians may ponder the irony that if Mr. Trump had not denied that the pandemic was real or 
a serious threat, had not claimed it would just disappear spontaneously, had instead engaged his 
presidential pandemic leadership responsibility and utilized, rather than denied the importance and 
value of public health and medical science, he might have won his 2020 re-election campaign. These 
retrospective historical analyses should become mandatory reading for all elected leaders who may be 
called upon to respond to the next emerging pandemic pathogen. Mr. Trump was defeated by SARS-
CoV-2 more than by any other factor, but at an immense cost of American life and avoidable suffering. 
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